The TCR-based therapy market is projected to grow at an annualized rate of 51%
Given the recent approval of a TCR-based therapy, industry stakeholders have initiated several R&D efforts focused on evaluating the potential of such therapy candidates against various disease indications
For additional details, please visit https://www.rootsanalysis.com/....reports/tcr-based-th or email sales@rootsanalysis.com
Like
Comment
Share
